Objectives: Vitamin D (25(OH)D) status has been extensively evaluated in different populations and care settings. A negative relationship between glycated hemoglobin (HbA1c) and serum 25(OH)D levels in outpatients with diabetes has been reported, while data about 25(OH)D status in inpatients with diabetes are inconsistent. The aim of the study was to evaluate 25(OH)D levels in a large series of inpatients with type 1 and type 2 diabetes and in an age-, sex-, serum creatinine-, and HbA1c-matched group of outpatients with diabetes.
Introduction
Vitamin D status has been extensively evaluated in different populations and care settings, with a vitamin D deficiency (VDD) 1 prevalence of 50-90%, depending on the used diagnostic criteria and the study population. 2 Hypovitaminosis D is usually exacerbated in seasons with lower ultraviolet B (UVB) irradiation. Low UVB exposure in the modern lifestyle and atmospheric pollution partially blocking UVB are among the factors that contribute to the risk of VDD. 3,4,5. Patients with diabetes have reportedly a higher prevalence of VDD in comparison to the general population, 3, 4 and a role of vitamin D supplementation in improving insulin secretion and sensitivity has been suggested. 6 VDD, indeed, contributes to both the initial insulin resistance and the subsequent onset of diabetes caused by â-cell death. Vitamin D reduces inflammation, which is a major process in inducing insulin resistance.
Vitamin D maintains the normal resting levels of both
Ca2+ and reacting oxygen species that are elevated in the â-cells during diabetes. 7, 8 Moreover, in outpatients with diabetes a negative relationship between glycated hemoglobin (HbA1c) and It is well-known that inpatients with diabetes have worse health outcomes than inpatients without diabetes, with increased risk of all-cause death. 11, 12 VDD has also been related to worse outcomes in inpatients, such as length of stay (LOS), morbidity, and mortality. [13] [14] [15] [16] [17] At present, however, no data are available about differences of 25(OH)D status between in-and outpatients with diabetes, nor for the impact of VDD on glycemic control in inpatients with diabetes.
This study was thus aimed to evaluate 25(OH)D levels in a large series of inpatients with type 1 and type 2 diabetes and in an age-, sex-, serum creatinine-, and
HbA1c-matched group of outpatients with diabetes.
Subjects and Methodology
The research was carried out in accordance with the No formal consent is required for this type of study.
Design
This was a retrospective case-control study that enrolled 540 subjects with diabetes.
We performed a 1:1 matched case-control study on 270
inpatients with diabetes consecutively hospitalized in our Endocrine Unit from January 2011 to December 2013 as cases and 270 age-, sex-, serum creatinine-, and HbA1c-matched outpatients with diabetes as controls. Gender distribution was identical in the two groups and the maximal allowed differences regarding age, serum creatinine and HbA1c were ± 2 years, ± 0.1 mg/dL and ± 0.2%, respectively.
Patients
All subjects lived in Piedmont, a Region in the NorthWestern part of Italy, were of Caucasic ancestry, and on the whole were exposed to the same UV spectrum of sunlight. 
Measurements
The collected data included age, sex, BMI, HbA1c, 25
(OH)D, creatinine, and month of evaluation. In addition, for inpatients we evaluated LOS and admission diagnosis. All data were obtained from the letter of discharge and classified according to the diagnosis related group into the followings: diabetic foot infection, other infections, acute nephropathy, heart disease, cerebrovascular disease, and others.
In a subgroup of 89 inpatients, not statistically different from the whole group of inpatients for age, sex, glycemic control and LOS, we also evaluated the 
Statistical analysis
Variables were tested for normal distribution (WilkShapiro's test) and, where confirmed, results were expressed as mean ± standard deviation (SD).
Otherwise, they were given as median and interquartile range (IQR). Our study shows a high prevalence of VDD, even severe, in comparison to data previously reported in healthy subjects living at the same latitude. 22 Moreover, our Strengths and limits of our study need to be taken into account. The 1:1 matched case-control design of the study strengthens the evidence and supports the results.
Results
In addition, all examinations and measurements were performed in the same laboratory, assuring a good quality of data. Moreover, this is the first study assessing vitamin D status in inpatients with diabetes. The greatest limit is the single-spot measurement of biomarkers.
In conclusion, VDD is common in diabetic inpatients and more frequent than in outpatients with diabetes. 25(OH) D status in inpatients seems to be influenced by the acute inflammatory condition; for this reason, we suggest that hospitalization may not be the appropriate setting for 25(OH)D evaluation in diabetic populations.
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